CXCL1 and Alzheimer disease: More specifically, AD-MSCs downregulated IL-4, CTACK, TPO, and IL-13 (Figure 4C), while DP-MSCs downregulated CXCL1 and TRAC and upregulated Eotaxin-1 and Leptin, which are also linked to bone metabolism (Figure 4D).